Osteoporosis
Updated March 2026 ยท 9 min read

Osteoporosis Diagnosis in Canada: FRAX, CAROC, and What to Expect

Getting an osteoporosis diagnosis in Canada involves more than a bone scan. It means understanding your fracture risk, interpreting your DXA results, and working with tools like FRAX and CAROC to decide on next steps. Here's what the process actually looks like.

Who Should Be Screened for Osteoporosis?

Osteoporosis Canada recommends formal bone health assessment based on age and risk factors. The general screening thresholds for DXA scanning covered by provincial health plans are:

Provincial coverage for DXA scans varies. In Ontario, women 65+ and men 65+ with risk factors are covered under OHIP. In British Columbia, women and men 65+ are covered. Alberta covers women 50+ and men 60+ with risk factors. Check with your provincial health authority or family doctor for current eligibility in your province.

Ask your family doctor: If you're 50 or older and have never had a bone density test, ask your GP whether you're eligible. Many Canadians who qualify for covered DXA scans have never had one simply because it was never mentioned at an appointment.

The DXA Scan: What It Measures

DXA (Dual-energy X-ray Absorptiometry) is the standard test for measuring bone mineral density (BMD). It uses very low doses of X-ray radiation โ€” less than you'd receive on a transatlantic flight โ€” to measure bone density at two key sites: the lumbar spine (L1-L4) and the femoral neck (hip). These are the most predictive sites for fracture risk.

The scan takes about 15โ€“20 minutes, is painless, and requires no special preparation. You remain clothed but may need to remove metal objects. Results are reported as T-scores and Z-scores.

Understanding Your T-Score

The T-score compares your bone density to a young healthy adult at peak bone mass. This is the primary diagnostic score for osteoporosis in adults over 50:

T-Score RangeClassificationWhat It Means
-1.0 and aboveNormalBMD within the normal range for peak bone mass
-1.0 to -2.5Osteopenia (low bone mass)Below normal but not osteoporotic; monitoring and prevention focus
-2.5 or belowOsteoporosisSignificantly reduced bone density; treatment typically recommended
-2.5 or below + fragility fractureSevere osteoporosisEstablished osteoporosis; treatment strongly indicated

Understanding Your Z-Score

The Z-score compares your BMD to others of the same age and sex. It's used primarily in younger adults, premenopausal women, and men under 50. A Z-score below -2.0 suggests that your bone loss exceeds what's typical for your age โ€” which often points to secondary causes (medications, medical conditions) worth investigating.

FRAX: The Global Fracture Risk Tool

A T-score alone doesn't tell the whole story. Two people with the same T-score can have very different fracture risks depending on their age, weight, family history, smoking status, and other factors. The FRAX tool (Fracture Risk Assessment Tool), developed by the University of Sheffield and validated for the Canadian population, integrates all of these variables to calculate a 10-year probability of:

Your doctor can calculate your FRAX score using the online tool at sheffield.ac.uk/FRAX (select Canada as the country). Importantly, FRAX can be calculated with or without a DXA result โ€” making it useful even before a scan. The Canadian version uses Canadian epidemiological fracture data for its calculations.

What FRAX Scores Mean in Canada

Canadian guidelines (from Osteoporosis Canada, updated 2023) use FRAX thresholds to categorize risk and guide treatment decisions:

10-Year Major Fracture RiskRisk CategoryRecommendation
Less than 10%LowLifestyle modifications (calcium, vitamin D, exercise). Reassess in 5 years.
10โ€“20%ModerateClinical judgment; consider pharmacotherapy if other risk factors present
Greater than 20%HighPharmacotherapy strongly recommended alongside lifestyle measures

CAROC: The Canadian-Specific Risk Tool

CAROC (Canadian Association of Radiologists and Osteoporosis Canada) is a simplified risk assessment tool developed specifically for Canadian clinical practice. It uses three inputs to categorize fracture risk into low, moderate, or high:

  1. The femoral neck T-score from your DXA scan
  2. Your age and sex
  3. The presence of major risk factors: prior fragility fracture after age 40, or current systemic glucocorticoid use (prednisone at doses of 7.5 mg/day or equivalent for 3+ months)

CAROC is widely used in Canadian primary care because of its simplicity. It requires only a DXA result (which many patients already have) and two clinical questions. The risk categories align with the same treatment thresholds as FRAX.

FRAX vs CAROC: Both tools are validated for Canadian use and recommended by Osteoporosis Canada. FRAX incorporates more variables and can be used without a DXA scan. CAROC is simpler and works directly from DXA results. Your doctor may use either or both โ€” the goal is the same: matching your actual fracture risk with the right intervention intensity.

What Happens at Your First Osteoporosis Appointment

If your family doctor suspects osteoporosis or identifies you as a candidate for screening, the process typically unfolds as follows:

  1. Risk factor review: Your doctor will ask about fracture history, family history (especially parental hip fracture), falls, medications (particularly corticosteroids), medical conditions associated with bone loss, alcohol and tobacco use, and calcium and vitamin D intake.
  2. DXA referral: You'll receive a referral for a DXA scan. In most Canadian cities, wait times range from a few weeks to a few months. Private clinics offer faster access in some provinces.
  3. Blood tests: To rule out secondary causes of bone loss, your doctor may order bloodwork including complete blood count, calcium, phosphate, creatinine, thyroid function (TSH), 25-hydroxyvitamin D levels, and in some cases protein electrophoresis or parathyroid hormone.
  4. Risk calculation: Once DXA results are available, your doctor calculates your CAROC or FRAX risk category.
  5. Treatment discussion: Based on your risk category, you'll discuss whether lifestyle changes alone are sufficient, or whether pharmacotherapy (bisphosphonates, denosumab, romosozumab, or others) is appropriate.

Secondary Causes: The Often-Missed Diagnosis

Up to 30% of postmenopausal women and 50% of men with osteoporosis have a secondary cause โ€” an underlying medical condition or medication contributing to bone loss. Common secondary causes in the Canadian population include:

If your Z-score is below -2.0, or if your bone loss seems out of proportion to your risk factors, ask your doctor whether secondary causes have been evaluated.

After the Diagnosis: Monitoring Over Time

Osteoporosis management isn't a one-time event. Serial DXA scans are used to monitor the effectiveness of treatment and the natural progression of bone loss. Canadian guidelines recommend:

A decrease in BMD of more than 3โ€“5% at the spine or hip on repeat DXA is considered a significant change and warrants reassessment of treatment compliance, secondary causes, and possibly medication adjustment.

For proven bone health interventions, see: Our guides on calcium supplementation, vitamin D and bone health, osteoporosis medications in Canada, and DXA bone density testing.
Medical Disclaimer: This article provides general educational information about osteoporosis diagnosis and is not a substitute for professional medical advice. Fracture risk assessment and treatment decisions should be made with your doctor based on your individual health history. Always consult a qualified healthcare provider before starting any new treatment.